LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

Share · US50180M1080 · LBRX (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LB Pharmaceuticals Inc Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
29.04.2026 16:26
Current Prices from LB Pharmaceuticals Inc Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
IEXG: IEX
IEX
LBRX
USD
29.04.2026 16:26
30,87 USD
-0,52 USD
-1,64 %
XNAS: NASDAQ
NASDAQ
LBRX
USD
29.04.2026 16:09
31,15 USD
-0,23 USD
-0,73 %
Share Float & Liquidity
Free Float 74,30 %
Shares Float 21,31 M
Shares Outstanding 28,67 M
Company Profile for LB Pharmaceuticals Inc Common Stock Share
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.

Company Data

Name LB Pharmaceuticals Inc Common Stock
Company LB Pharmaceuticals Inc Common Stock
Symbol LBRX
Website https://lbpharma.us
Primary Exchange XNAS NASDAQ
ISIN US50180M1080
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Heather D. Turner
Market Capitalization 900 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address One Pennsylvania Plaza, 10119 New York
IPO Date 2025-09-11

Ticker Symbols

Name Symbol
NASDAQ LBRX
More Shares
Investors who hold LB Pharmaceuticals Inc Common Stock also have the following shares in their portfolio:
EBRD 22/27 MTN
EBRD 22/27 MTN Bond
Norddeutsche Landesbank -GZ- EO-IHS 24(30)
Norddeutsche Landesbank -GZ- EO-IHS 24(30) Unbekannt